Iran approves use of U.S.-made Johnson & Johnson coronavirus vaccine
Authorities in Tehran have approved the use of the coronavirus vaccine produced by US pharmaceutical giant Johnson & Johnson as Iran faces a fifth wave of COVID-19 infections.
“Johnson & Johnson’s single-dose corona vaccine has been approved,” Mohammad Reza Shanehsaz, head of the Iranian Food and Drug Administration, said on September 16.
Shanehsaz said the single-injection Sputnik Light vaccine developed by Russia has also been approved in Iran.
Iran’s decision to approve the Johnson & Johnson vaccine comes eight months after Supreme Leader Ayatollah Ali Khamenei banned vaccines produced in Britain and the United States, saying those countries do not were “not trustworthy”.
However, Iranian President Ebrahim Raisi, who took office in August, has pledged to prioritize tackling the pandemic.
Iran uses its own COV vaccine Iran Barakat, as well as Russia’s Sputnik V, India’s Covaxin, and a version of the Oxford / AstraZeneca vaccine developed by the British and produced by a Russian-Korean joint venture.
Iran’s health ministry said about 13 million of the country’s 83 million people have been fully immunized.
According to the Johns Hopkins Coronavirus Resource Center, Iran has recorded more than 5,378,000 infections and 116,072 deaths from COVID-19 since the start of the pandemic, making it the hardest-hit country in the Middle East.
Iran has recorded nearly 16,000 deaths from COVID-19 in the past 28 days.